Given the design of this study, where the TXB4-TrkB BSA was administered 24 h before the toxin injection, it is not clear if delayed treatment with the TXB4-TrkB BSA is neuroprotective in experimental PD, but this issue can be resolved with future investigations. Here, NTRK2 is linked to Parkinson disease.